Skip to main content

MoneyWorks4Me

The sales surged to Rs. 61419.20 millions, up 35.04% for the September 2026 quarter as against Rs. 45481.10 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2026 reported a huge growth of 54.42% to Rs. 8712.90  millions from Rs. 5642.20 millions.Operating Profit saw a handsome growth to 17957.40 millions from 12563.80 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 61419.20 45481.10 35.04 118830.50 101429.90 17.16 207546.40 229774.00 -9.67
Other Income 810.10 727.90 11.29 2211.80 1765.00 25.31 4193.30 3791.40 10.60
PBIDT 17957.40 12563.80 42.93 39001.20 32696.20 19.28 66000.20 72168.40 -8.55
Interest 2769.60 2483.30 11.53 5554.40 4867.50 14.11 9478.40 9538.90 -0.63
PBDT 15187.80 10080.50 50.67 33131.50 24952.30 32.78 51058.40 62629.50 -18.48
Depreciation 3157.90 3363.00 -6.10 6237.10 6472.20 -3.63 13117.20 12867.40 1.94
PBT 12029.90 6717.50 79.08 26894.40 18480.10 45.53 37941.20 49762.10 -23.75
TAX 3317.00 1075.30 208.47 7030.10 5387.30 30.49 11707.00 7481.30 56.48
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 8712.90 5642.20 54.42 19864.30 13092.80 51.72 26234.20 42280.80 -37.95
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 29.24 27.62 5.84 32.82 32.24 1.82 31.80 31.41 1.25
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..